Skip to main content
. 2011 Nov;77(22):8015–8024. doi: 10.1128/AEM.05933-11

Table 4.

Total viable counts (log10 CFU g−1) of fecal samples from patient-sibling pairs 1 and 2 (longitudinal study) on EMB agar, VA, MRS agar, M144, DRCM, MBP, and MCB

Medium No. of samplesa
Count (log10 CFU g−1) (mean ± SE)
Log differenceb
Total
Minimum–maximum
Patients Siblings Patients Siblings Patients Siblings
EMB agar (Enterobacteriaceae) 11 14 5.9 ± 0.7 5.5 ± 0.2 0.0–7.0 0.3–6.4 −0.4
VA (Veillonella spp.) 13 12 4.3 ± 0.9 5.9 ± 0.3 0.0–8.6 0.0–8.0 1.6
MRS agar (lactic acid bacteria) 12 11 5.8 ± 0.9 7.9 ± 0.2 0.0–8.2 0.3–8.8 2.1
M144 (Bifidobacterium spp.) 12 12 5.9 ± 0.9 8.3 ± 0.2 0.0–8.8 0.0–8.9 2.4
DRCM (clostridia) 12 12 5.9 ± 0.9 7.9 ± 0.3 0.0–8.7 0.0–9.0 2.0
MBP (Bacteroides-Prevotella spp.) 11 12 3.9 ± 0.8 6.6 ± 0.5 0.0–7.7 2.3–8.6 2.7
MCB (general medium for colon bacteria) 12 10 5.9 ± 0.9 7.8 ± 0.4 0.0–8.7 0.0–9.2 1.9
a

Only 7 samples were obtained from patient 2. Noncountable data were excluded.

b

Difference between log10 mean CFU g−1 values for CF patients and siblings for each medium.